Recently, we identified in vivo that fibroblasts in SLE nonlesional and lesional skin exhibit evidence of exposure to inflammatory cytokine stimulation, including TNF-α, IL-1β, and type I and type II IFNs (5). This evidence concerns the gene TNF and systemic lupus erythematosus.